Fermenta Biotech subsidiary FESPL to issue shares to Aasava
Fermenta Biotech Limited's subsidiary, FESPL, entered into a share subscription agreement with Aasava Management Services LLP on July 20, 2026, to issue 7,17,949 equity shares for ₹86,15,388. This investment will reduce Fermenta Biotech's stake to 91.76%, causing FESPL to cease being a wholly-owned subsidiary. FESPL reported a revenue of ₹400.53 lakhs and a net worth of ₹340.24 lakhs for the financial year ended March 31, 2026.

*this image is generated using AI for illustrative purposes only.
Fermenta Biotech Limited announced that its subsidiary, Fermenta Environment Solutions Private Limited (FESPL), will cease to be a wholly-owned subsidiary following a share subscription agreement with Aasava Management Services LLP. The agreements, signed on July 20, 2026, involve the issuance of 7,17,949 equity shares in FESPL to Aasava for a total subscription amount of ₹86,15,388. This strategic move is expected to be value accretive for FESPL and aligns the interests of Aasava, a long-time marketing associate and consultant, with the subsidiary's growth.
Post-allotment, Fermenta Biotech will retain a 91.76% shareholding in FESPL. The transaction is not classified as a slump sale or a related party transaction, and FESPL does not qualify as an 'Undertaking' under Section 180 of the Companies Act, 2013, or Regulation 37A of the SEBI Listing Regulations. The investment by Aasava reflects confidence in the environment solutions business and its expansion strategy.
The subsidiary was incorporated on May 1, 2025. According to the audited financial statements as on March 31, 2026, FESPL reported a total revenue of ₹400.53 lakhs, which accounted for 0.73% of Fermenta Biotech's consolidated figures. The net worth of FESPL stood at ₹340.24 lakhs, representing 0.85% of the consolidated net worth of the parent company.
The allotment of equity shares to Aasava is anticipated to be completed by or before July 27, 2026. No consideration will be received by Fermenta Biotech from this transaction, as the subscription amount is payable directly to FESPL. Aasava Management Services LLP is registered under the Limited Liability Partnership Act, 2008, and is not part of the promoter or promoter group of Fermenta Biotech.
Key Financials of FESPL
| Metric | Amount | % of Consolidated Figures |
|---|---|---|
| Total Revenue (FY26) | ₹400.53 lakhs | 0.73% |
| Net Worth (as on March 31, 2026) | ₹340.24 lakhs | 0.85% |
Transaction Details
| Particular | Details |
|---|---|
| Shares Issued | 7,17,949 equity shares |
| Subscription Amount | ₹86,15,388 |
| Expected Allotment Date | July 27, 2026 |
| Parent Stake Post-Allotment | 91.76% |
Historical Stock Returns for Fermenta Biotech
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.86% | -2.11% | +27.16% | +36.82% | +36.82% | +36.82% |
How will the infusion of ₹86.15 lakhs specifically be utilized by FESPL to scale its environment solutions operations?
Does this strategic partnership with Aasava signal a shift in Fermenta Biotech's strategy towards diversifying its revenue streams?
What are the projected revenue contributions of FESPL to the consolidated financials over the next 3-5 years?


































